antifolate drugs | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

21,208 results for “antifolate drugs”

FDA Expands Methotrexate Approval to Include Pediatric ALL and pJIA

Brain Cancer Canada Awards $170K for Two Glioblastoma Research Projects Targeting Treatment Resistance

Byondis Unveils Novel ADC Platforms to Combat Cancer Drug Resistance at AACR 2026

FDA Rejects Lykos Therapeutics' MDMA-Assisted Therapy for PTSD, Citing Data Concerns

FDA Clarifies cGMP Expectations for Investigational Drugs

Hong Kong Approves Two New Drugs for Hypercalcemia Under "1+" Mechanism

Nura Bio Secures $140 Million to Advance Neuroprotective Drug NB-4746 Targeting SARM1

Sarepta Halts Development of Next-Generation Duchenne Muscular Dystrophy Drugs Due to Safety Concerns

FDA Reviews Accelerated Approvals for Keytruda, Opdivo, and Tecentriq in Multiple Cancers

Byondis Appoints Christoph Korpus as CEO to Lead ADC Technology Platform Development

Page 1 of 980